Good data from the clinical trial (PMID 33782832) directly studying oral semaglutide + rosuvastatin, and from drugs.com/medcentral. Here's the full answer:
GLP-1 (semaglutide 0.25 mg) + Rosuvastatin - Short Answer
These two medications are generally safe to take together. No clinically significant drug interaction has been found between semaglutide and rosuvastatin. You do not need to avoid combining them.
What the Evidence Says
No significant pharmacokinetic interaction. A dedicated
clinical pharmacokinetics study (Jordy et al., 2021) specifically tested oral semaglutide combined with rosuvastatin. The result: oral semaglutide caused only a
small increase in rosuvastatin exposure, which the researchers concluded "is not expected to be of clinical relevance." No new safety concerns were identified.
For
subcutaneous semaglutide (the injectable form - Ozempic/Wegovy), the
MedCentral prescribing monograph states it "did not affect the absorption of orally administered drugs to any clinically important extent."
Why there's even a theoretical question: Semaglutide slows gastric emptying, which could delay how quickly oral drugs absorb. But rosuvastatin is absorbed gradually through the intestinal wall over several hours, so this delay has minimal real-world impact on how much gets into your system.
Semaglutide does not affect CYP enzymes. Rosuvastatin's metabolism is not disrupted - semaglutide has very low potential to inhibit or induce cytochrome P450 enzymes or drug transporters.
Practical Points
- Take both as your doctor prescribed - no timing adjustment or dose change is needed based on the interaction data.
- 0.25 mg is the standard starting dose for semaglutide (Ozempic/Wegovy). GI side effects (nausea, diarrhea) are most common in the early weeks - if you get significant nausea and vomiting, mention it to your provider, as persistent vomiting can affect how well oral medications absorb.
- Lipid monitoring: Semaglutide on its own can improve triglycerides and HDL. Your doctor may recheck your lipid panel after a few months to see if your rosuvastatin dose needs adjusting (possibly downward).
- Rosuvastatin note (independent of semaglutide): Routine urinalysis monitoring for proteinuria/hematuria is recommended with rosuvastatin - this is unrelated to the combination, just standard practice.
Disclaimer: This is general medical information, not a substitute for advice from your prescribing doctor or pharmacist, who knows your full health history. Always confirm with them before making any changes.